1.
INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA. J Popl Ther Clin Pharmacol [Internet]. 2024 Sep. 20 [cited 2024 Sep. 28];31(9):1502-18. Available from: https://jptcp.com/index.php/jptcp/article/view/7959